Skip to main content

Table 3 Prevalence of CTC graded gastrointestinal (GI) and genitourinary (GU) toxicities at each follow-up

From: Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Follow-up (months) 1 3 6 9 12 18 24
Toxicity Grade % % % % % % %
Bowel Frequency/Urgency 0 72 83 78 81 91 95 93
  1 23 16 20 18 8 5 7
  2 5 1 1 1 1 0 0
Proctitis 0 86 97 95 95 99 99 100
  1 14 3 5 5 1 1 0
  2 0 0 0 0 0 0 0
Rectal Bleeding 0 94 98 96 95 98 93 96
1 6 2 4 5 2 7 4
  2 0 0 0 0 0 0 0
Highest GI 0 60 79 71 73 87 89 89
  1 35 20 28 26 12 11 11
  2 5 1 1 1 1 0 0
Hematuria 0 96 97 99 96 97 98 94
  1 4 2 0 3 2 1 4
  2 0 1 0 0 0 0 0
  3 0 0 1 1 1 1 1
Dysuria 0 71 91 97 88 93 96 93
  1 29 9 3 13 7 4 7
  2 0 0 0 0 0 0 0
Incontinence 0 85 86 86 84 89 89 88
  1 13 14 14 16 11 10 12
  2 2 0 0 0 0 1 0
Urinary Frequency/Urgency 0 81 90 90 93 93 90 88
1 19 10 9 7 6 8 11
2 0 0 1 0 1 2 1
Retention 0 55 64 63 70 75 70 76
  1 10 11 14 11 9 11 9
  2 35 24 23 19 16 19 16
Highest GU 0 28 52 53 54 59 53 57
  1 36 23 23 26 23 26 26
  2 35 25 23 19 17 20 17
  3 0 0 1 1 1 1 1